Kabra Drugs Share Price
09 Nov, 2026 4:01 PM (IST)
Kabra Drugs Performance
- Today's Low
- ₹18
- Today's High
- ₹18
- 52 Week Low
- ₹15
- 52 Week High
- ₹36
- Open Price₹18
- Previous Close₹17
- Volume42,611
- 50 DMA₹18.30
- 100 DMA₹20.10
- 200 DMA₹21.50
Kabra Drugs Chart
Investment Returns
- Over 1 Month -2.25%
- Over 3 Month -26.63%
- Over 6 Month -33.52%
- Over 1 Year -8.18%
Smart Investing Starts Here Start SIP with Kabra Drugs for Steady Growth!
Kabra Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 5.5
- PEG Ratio
- 0
- Market Cap Cr
- 42
- P/B Ratio
- 1.3
- Average True Range
- 1.4
- EPS
- 3.2
- Dividend Yield
- 0
- MACD Signal
- -0.5
- RSI
- 55.09
- MFI
- 45.62
Latest Stock News Updates
Undertaking for Non-Applicability of Regulation 32 of SEBI (LODR)
- BSE India
- 4 days 1 hour ago
Financial Results for the quarter ended 30-September-2026.
- BSE India
- 4 days 1 hour ago
Outcome of Board Meeting held on 06-November-2026
- BSE India
- 4 days 1 hour ago
Kabra Drugs Financials
Kabra Drugs Technicals
EMA & SMA
- Bearish Moving Average 7
- Bullish Moving Average 9
- 20 Day
- ₹16.90
- 50 Day
- ₹18.30
- 100 Day
- ₹20.10
- 200 Day
- ₹21.50
Resistance and Support
- R3 19.00
- R2 18.70
- R1 18.20
- S1 17.50
- S2 17.20
- S3 16.70
Kabra Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-11-06 | Quarterly Results | |
| 2026-09-02 | Others | |
| 2026-08-12 | Quarterly Results | |
| 2026-05-29 | Quarterly Results | |
| 2026-05-06 | Others | Inter-alia, to consider 1. Pharmaceutical manufacturing & marketing expansion of own brands. 2. Defense & AI Integration: To evaluate opportunities in defense manufacturing. 3. Other business matters. |
About Kabra Drugs
Kabra Drugs engaged in the business of pharmaceutical manufacturing and trading in pharma related products. View More- NSE Symbol
- KABRADG
- BSE Symbol
- 524322
- ISIN
- INE323K01017
Similar Stocks to Kabra Drugs
Popular Stocks
Kabra Drugs FAQs
Kabra Drugs share price is ₹17 As on 10 November, 2026 | 20:35
The Market Cap of Kabra Drugs is ₹42.3 Cr As on 10 November, 2026 | 20:35
The P/E ratio of Kabra Drugs is 5.5 As on 10 November, 2026 | 20:35
The PB ratio of Kabra Drugs is 1.3 As on 10 November, 2026 | 20:35
The 52 week High & Low of Kabra Drugs is ₹35.5/₹15.2 respectively As on 10 November, 2026 | 20:35
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.